• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA CPS1-IT1 是一个正预后因子,并抑制卵巢上皮性癌的肿瘤发生。

Long non-coding RNA CPS1-IT1 is a positive prognostic factor and inhibits epithelial ovarian cancer tumorigenesis.

机构信息

Department of Obstetrics and Gynecology, People's Hospital of Linyi City, Linyi, Shandong Province, China.

出版信息

Eur Rev Med Pharmacol Sci. 2017 Jul;21(14):3169-3175.

PMID:28770969
Abstract

OBJECTIVE

The aim of the present study was to explore the prognostic value of long non-coding RNA CPS1-IT1 (CPS1-IT1) expression in epithelial ovarian cancer (EOC) patients and identify the effect of CPS1-IT1 on cell proliferation and apoptosis of EOC cells.

PATIENTS AND METHODS

Expression levels of CPS1-IT1 in tissues and cells were detected by the Real-time quantitative RT-PCR assay. The χ2-test was used to analyze the relationship between CPS1-IT1 expression and the clinicopathological characteristics. Survival analysis was performed using the Kaplan-Meier method and Cox's proportional hazards model. The capacity for cellular proliferation was measured with cell counting Kit-8. Cell apoptosis assays were performed using flow cytometry. Western blot was used to detect the expression levels of cell apoptosis-related proteins.

RESULTS

We observed that CPS1-IT1 was significantly downregulated in EOC cell lines and tissue samples. The expression of CPS1-IT1 was significantly associated with FIGO stage and lymph node metastases. In addition, EOC patients in the low tissue CPS1-IT1 expression group had significantly shorter 5-year overall survival time than those in the high tissue CPS1-IT1 expression group. Furthermore, univariate and multivariable Cox regression analysis identified low CPS1-IT1 expression in EOC tissues as an independent poor prognostic marker of overall survival. It was also found that over-expression of CPS1-IT1 markedly promoted proliferation of EOC cells. Further studies revealed that over-expression of CPS1-IT1 induced cell apoptosis by through regulating apoptosis-related proteins.

CONCLUSIONS

CPS1-IT1 may be a functional tumor suppressor in EOC. It may also serve as an independent prognostic factor for patients with EOC.

摘要

目的

本研究旨在探讨长链非编码 RNA CPS1-IT1(CPS1-IT1)表达在卵巢上皮性癌(EOC)患者中的预后价值,并确定 CPS1-IT1 对 EOC 细胞增殖和凋亡的影响。

患者与方法

采用实时定量 RT-PCR 检测组织和细胞中 CPS1-IT1 的表达水平。采用χ2检验分析 CPS1-IT1 表达与临床病理特征的关系。采用 Kaplan-Meier 法和 Cox 比例风险模型进行生存分析。用细胞计数试剂盒-8 检测细胞增殖能力。用流式细胞术检测细胞凋亡。用 Western blot 检测细胞凋亡相关蛋白的表达水平。

结果

我们观察到 CPS1-IT1 在 EOC 细胞系和组织样本中显著下调。CPS1-IT1 的表达与 FIGO 分期和淋巴结转移显著相关。此外,CPS1-IT1 组织低表达组的 EOC 患者 5 年总生存率明显短于 CPS1-IT1 组织高表达组。进一步的单因素和多因素 Cox 回归分析表明,EOC 组织中 CPS1-IT1 低表达是总生存的独立预后不良因素。研究还发现,CPS1-IT1 的过表达显著促进了 EOC 细胞的增殖。进一步研究表明,CPS1-IT1 的过表达通过调节凋亡相关蛋白诱导细胞凋亡。

结论

CPS1-IT1 可能是 EOC 中的一种功能性肿瘤抑制因子。它也可能作为 EOC 患者的独立预后因素。

相似文献

1
Long non-coding RNA CPS1-IT1 is a positive prognostic factor and inhibits epithelial ovarian cancer tumorigenesis.长链非编码 RNA CPS1-IT1 是一个正预后因子,并抑制卵巢上皮性癌的肿瘤发生。
Eur Rev Med Pharmacol Sci. 2017 Jul;21(14):3169-3175.
2
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.在非浆液性上皮性卵巢癌患者中,FOXM1表达与化疗耐药及不良预后显著相关。
J Exp Clin Cancer Res. 2017 May 8;36(1):63. doi: 10.1186/s13046-017-0536-y.
3
Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.长链非编码RNA CPS1-IT1通过调节HIF-1α活性和抑制上皮-间质转化来抑制肝细胞癌的转移。
Oncotarget. 2016 Jul 12;7(28):43588-43603. doi: 10.18632/oncotarget.9635.
4
Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.lncRNA AB073614 的上调可作为上皮性卵巢癌预后的预测因子,并在体外和体内促进肿瘤生长。
Cancer Biomark. 2019;24(4):421-428. doi: 10.3233/CBM-182160.
5
Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.上皮性卵巢癌中polo样蛋白激酶1、P53和P21WAF1的调控异常提示预后不良。
Oncol Rep. 2015 Mar;33(3):1235-42. doi: 10.3892/or.2015.3723. Epub 2015 Jan 15.
6
Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer.miR-100 及其在人卵巢上皮性癌中的功能作用与预后相关性研究
Oncol Rep. 2012 Apr;27(4):1238-44. doi: 10.3892/or.2012.1625. Epub 2012 Jan 11.
7
High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.长链非编码RNA SPRY4-IT1的高表达预示着透明细胞肾细胞癌的预后不良。
Int J Clin Exp Pathol. 2014 Aug 15;7(9):5801-9. eCollection 2014.
8
MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression.miR-135a 在卵巢上皮性癌中作为肿瘤抑制因子发挥作用,并调节 HOXA10 的表达。
Cell Signal. 2014 Jul;26(7):1420-6. doi: 10.1016/j.cellsig.2014.03.002. Epub 2014 Mar 6.
9
Long non-coding RNA taurine-upregulated gene 1 predicts unfavorable prognosis, promotes cells proliferation, and inhibits cells apoptosis in epithelial ovarian cancer.长链非编码RNA牛磺酸上调基因1预测上皮性卵巢癌预后不良,促进细胞增殖并抑制细胞凋亡。
Medicine (Baltimore). 2018 May;97(19):e0575. doi: 10.1097/MD.0000000000010575.
10
LncRna CPS1-IT1 Suppresses Cell Proliferation, Invasion and Metastasis in Colorectal Cancer.长链非编码RNA CPS1-IT1抑制结直肠癌的细胞增殖、侵袭和转移。
Cell Physiol Biochem. 2017;44(2):567-580. doi: 10.1159/000485091. Epub 2017 Nov 17.

引用本文的文献

1
Role of DNA methylation and non‑coding RNAs expression in pathogenesis, detection, prognosis, and therapy‑resistant ovarian carcinoma (Review).DNA甲基化和非编码RNA表达在卵巢癌发病机制、检测、预后及治疗抵抗中的作用(综述)
Mol Med Rep. 2025 Jun;31(6). doi: 10.3892/mmr.2025.13509. Epub 2025 Apr 4.
2
A robust six-gene prognostic signature based on two prognostic subtypes constructed by chromatin regulators is correlated with immunological features and therapeutic response in lung adenocarcinoma.基于染色质调控因子构建的两个预后亚型的稳健的六个基因预后标志物与肺腺癌的免疫特征和治疗反应相关。
Aging (Albany NY). 2023 Nov 7;15(21):12330-12368. doi: 10.18632/aging.205183.
3
Regulation of LncRNAs in Melanoma and Their Functional Roles in the Metastatic Process.
长链非编码 RNA 在黑色素瘤中的调控及其在转移过程中的功能作用。
Cells. 2022 Feb 7;11(3):577. doi: 10.3390/cells11030577.
4
Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer.卵巢癌预后因素及生物标志物的研究进展
J Cancer. 2021 May 13;12(13):3976-3996. doi: 10.7150/jca.47695. eCollection 2021.
5
CPS1: Looking at an ancient enzyme in a modern light.CPS1:用现代的眼光看待古老的酶。
Mol Genet Metab. 2020 Nov;131(3):289-298. doi: 10.1016/j.ymgme.2020.10.003. Epub 2020 Oct 10.
6
Development of a nine-lncRNA signature as a novel prognostic marker of estrogen receptor-negative breast cancer.开发一种九lncRNA特征作为雌激素受体阴性乳腺癌的新型预后标志物。
Oncol Lett. 2020 Apr;19(4):2979-2988. doi: 10.3892/ol.2020.11391. Epub 2020 Feb 13.
7
Comprehensive bioinformatics analysis of lncRNAs in gastric cancer.胃癌中lncRNAs的综合生物信息学分析
Oncol Lett. 2019 Jan;17(1):1279-1291. doi: 10.3892/ol.2018.9707. Epub 2018 Nov 15.